hybridization

The firm will use the undisclosed amount to optimize the protocols for its genomic-selection application and to start building a sales and marketing force that "will become more visible in the second half of this year," CEO Fred Dom said.

In Print

Premium

Microarray-Related Papers of Note, February 2009

IP Roundup

Premium

Seiko Epson, SRU Biosystems, University of California, Roche NimbleGen, Illumina

According to unaudited, pro forma data, Panomics would have added $10.7 million to Affy's total revenues for the nine months ended Sept. 30, 2008, and $11 million to the company's top line in fiscal year 2007.

The company claims that compared to other targeted sequence-enrichment methods, its approach leads to more uniform coverage, or less enrichment bias. RainDance said it plans to offer up to 4,000 amplifications in a single tube later this year.

Both companies are offering users of second-generation sequencing systems new tools to select portions of the genome for targeted resequencing but have optimized their products for different sequencing platforms.

BioArray Briefs

Premium

Signature Genomic Labs, HTG, CRL Global Services, Decode Genetics, Kreatech, BioMicro, Agilent, Scienion

Signature Genomics Lab said that it is the first laboratory to receive a New York permit to perform microarray-based comparative genomic hybridization.

Kreatech will distribute BioMicro's microfluidics and microarray tools in several countries, and a collaboration is in the works.

In the first part of a two-part interview, Mann discusses the state of technology in proteomics and what still needs to get done for proteomics to cross to the clinical side.

Pages

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.